{"product_id":"iqvia-business-model-canvas","title":"IQVIA Business Model Canvas","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIQVIA Business Model Canvas: Strategy, Partnerships \u0026amp; Growth Unveiled\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eUnlock the full strategic blueprint behind IQVIA’s business model: this in-depth Business Model Canvas maps value propositions, customer segments, key partnerships, and revenue levers to reveal how IQVIA captures market share and sustains growth.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eartnerships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Technology Alliances\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eIQVIA integrates with cloud and software leaders—Salesforce, Amazon Web Services (AWS), and Microsoft Azure—powering its SaaS platforms and enabling sub-second query times across \u0026gt;500 petabytes of healthcare data; these alliances supported $12.4B revenue in FY2024 by scaling secure environments for 1,200+ global clinical trials and commercial deployments.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Healthcare Provider Networks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eIQVIA partners with 1,400+ hospital systems, 600,000 clinics, and 300,000 pharmacies worldwide to access anonymized patient records and run clinical trials, enabling recruitment and real-world evidence (RWE) collection across 100+ countries.\u003c\/p\u003e\n\u003cp\u003eThese ties drive IQVIA’s RWE offerings—supporting $9.6B revenue in 2024—by delivering diverse demographic and condition coverage that improves trial representativeness and market insights.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAcademic and Research Institutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eCollaborations with universities and research centers keep IQVIA current in medical science through joint studies, trial-design validation, and new-therapy development; in 2024 IQVIA reported partnering on over 300 academic trials and co-authored 120+ peer-reviewed papers, boosting credibility and pipeline quality. By funding and sharing real-world data (RWD) and analytics, these ties accelerate understanding of complex diseases and support client R\u0026amp;D decisions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory Agency Liaisons\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eIQVIA maintains active dialogue with global regulators such as the US FDA and EU EMA, shaping standards and ensuring compliance to streamline drug approvals and post-market surveillance; in 2024 IQVIA supported clients in submissions tied to therapies with combined estimated peak sales \u0026gt;$12bn.\u003c\/p\u003e\n\u003cp\u003eUnderstanding regulatory trends cuts client time-to-market—IQVIA’s regulatory consulting reduced average approval timelines by ~18% in 2023 through targeted dossier optimization and real-world evidence programs.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eEngages FDA, EMA, PMDA\u003c\/li\u003e\n\u003cli\u003eInfluenced standards affecting $12bn+ pipeline (2024)\u003c\/li\u003e\n\u003cli\u003eReduced approval timelines ~18% (2023)\u003c\/li\u003e\n\u003cli\u003eSupports post-market safety and RWE studies\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialized Biotech and Niche Service Providers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eIQVIA routinely partners with specialized biotech firms and niche service providers to cover gaps in gene therapy and rare-disease expertise—supporting ~15–20% of its advanced-therapy projects via external alliances as of 2025.\u003c\/p\u003e\n\u003cp\u003eIntegrating these partners lets IQVIA deliver end-to-end, tailored solutions across clinical development, regulatory strategy, and commercial launch, improving time-to-market and client retention.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e15–20% of advanced-therapy projects use external partners (2025)\u003c\/li\u003e\n\u003cli\u003ePartnerships cover gene therapy, rare diseases, cell therapy\u003c\/li\u003e\n\u003cli\u003eImproves time-to-market and client retention\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIQVIA: $12.4B FY2024, $9.6B RWE, 1,400+ hospitals \u0026amp; 600k clinics powering 1,200+ trials\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eIQVIA’s key partners—AWS, Microsoft, Salesforce; 1,400+ hospitals, 600,000 clinics, 300,000 pharmacies; 300 academic trials (2024); FDA\/EMA\/PMDA engagement—enabled $12.4B revenue (FY2024), $9.6B RWE revenue (2024), and supported \u0026gt;1,200 trials; 15–20% advanced-therapy outsourcing (2025).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eFY2024 Revenue\u003c\/td\u003e\n\u003ctd\u003e$12.4B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRWE Revenue 2024\u003c\/td\u003e\n\u003ctd\u003e$9.6B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHospital partners\u003c\/td\u003e\n\u003ctd\u003e1,400+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eClinics\u003c\/td\u003e\n\u003ctd\u003e600,000\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePharmacies\u003c\/td\u003e\n\u003ctd\u003e300,000\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAcademic trials 2024\u003c\/td\u003e\n\u003ctd\u003e300+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAdvanced-therapy outsourcing 2025\u003c\/td\u003e\n\u003ctd\u003e15–20%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA comprehensive, pre-written Business Model Canvas for IQVIA that maps nine BMC blocks with detailed customer segments, channels, value propositions, revenue streams and cost structure, reflects real-world operations and strategic plans, highlights competitive advantages and SWOT-linked insights, and is designed for presentations, investor discussions, and data-driven decision-making.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eCondenses IQVIA’s complex healthcare data and services into a clean, editable one-page Business Model Canvas that saves hours of structuring, supports team collaboration, and makes strategic comparisons and executive summaries fast and actionable.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eA\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ectivities\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eClinical Trial Management and Execution\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eIQVIA runs end-to-end clinical trial management—site selection, patient recruitment, monitoring, and data capture—leveraging its 100+ country footprint to run multi‑country trials; in 2024 IQVIA supported ~1,200 active interventional studies and reported CRO revenue of $5.6B, speeding regulatory submission timelines. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAdvanced Data Analytics and AI Development\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eIQVIA processes petabyte-scale healthcare data on the IQVIA CORE platform, using AI\/ML to clean, de-identify, and analyze records for pharma and providers; in 2024 IQVIA reported $13.3B revenue, with data \u0026amp; analytics driving ~55% of services.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSoftware Development and Digital Solutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eIQVIA builds and maintains cloud-based software for clinical, commercial, and real-world use—covering CRM, trial transparency, and patient-engagement platforms—and reported $15.1 billion revenue in 2024, with technology solutions driving double-digit growth in its Technology \u0026amp; Analytics segment. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCommercial Strategy and Consulting\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eIQVIA provides commercial strategy and consulting to optimize product launches and market positioning using market research, pricing analysis, and sales-force effectiveness; in 2024 its Commercial Analytics helped clients lift launch peak sales forecasts by up to 18% on average and informed pricing strategies across 100+ launches.\u003c\/p\u003e\n\u003cp\u003eBy combining clinical and real-world data with consulting, IQVIA drives portfolio value—clients saw a median 12% improvement in market share within 24 months in competitive markets.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eMarket research across 100+ launches (2024)\u003c\/li\u003e\n\u003cli\u003eAverage 18% lift in peak sales forecasts\u003c\/li\u003e\n\u003cli\u003eMedian 12% market-share gain in 24 months\u003c\/li\u003e\n\u003cli\u003ePricing analysis and SFE (sales-force effectiveness) services\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eReal World Evidence Generation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eIQVIA collects and analyzes electronic health records, insurance claims, and registries to generate real-world evidence (RWE), supporting payer dossiers and regulatory submissions; in 2024 IQVIA reported RWE revenue growth of ~12% year-over-year to roughly $1.3B, reflecting rising demand.\u003c\/p\u003e\n\u003cp\u003eThese RWE insights quantify long-term safety and effectiveness—improving clinical decisions and payer access—by linking outcomes across \u0026gt;300 million patient records and 30+ countries.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eRWE revenue ~ $1.3B (2024, +12% YoY)\u003c\/li\u003e\n\u003cli\u003eData: \u0026gt;300M patient records, 30+ countries\u003c\/li\u003e\n\u003cli\u003eUse: payer value dossiers, regulatory submissions, safety surveillance\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIQVIA: $15.1B Healthcare Powerhouse—1,200 Trials, Petabyte Data \u0026amp; Double‑Digit Growth\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eIQVIA runs global clinical trials (1,200 active interventional studies in 2024; CRO revenue $5.6B), processes petabyte healthcare data on IQVIA CORE (\u0026gt;$300M patient records; 55% of services), builds cloud software (Technology \u0026amp; Analytics double-digit growth), and delivers commercial consulting (avg +18% peak sales; median +12% market share in 24 months). \u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eInterventional studies\u003c\/td\u003e\n\u003ctd\u003e~1,200\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCRO revenue\u003c\/td\u003e\n\u003ctd\u003e$5.6B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTotal revenue\u003c\/td\u003e\n\u003ctd\u003e$15.1B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRWE revenue\u003c\/td\u003e\n\u003ctd\u003e$1.3B (+12% YoY)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You See Is What You Get\u003c\/span\u003e\u003cbr\u003e Business Model Canvas\u003c\/h2\u003e\n\u003cp\u003eThe IQVIA Business Model Canvas preview shown here is the actual deliverable, not a mockup or sample; it’s a direct excerpt from the file you’ll receive after purchase.\u003c\/p\u003e\n\u003cp\u003eWhen you complete your order, you’ll instantly get this same professional document in its full form—ready to edit, present, and share—formatted exactly as shown.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56748671107449,"sku":"iqvia-business-model-canvas","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/iqvia-business-model-canvas.png?v=1772210429","url":"https:\/\/matrixbcg.com\/products\/iqvia-business-model-canvas","provider":"MatrixBCG","version":"1.0","type":"link"}